High Tower Advisors, LLC Ampio Pharmaceuticals, Inc. Transaction History

High Tower Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.16 - $0.47 $9,920 - $29,140	-62,000 Reduced 83.7%	12,075 $2,000
Q1 2022 May 12, 2022	BUY	$0.42 - $0.62 $19,320 - $28,520	46,000 Added 163.85%	74,075 $35,000
Q4 2021 Feb 10, 2022	BUY	$0.56 - $1.71 $6,703 - $20,470	11,971 Added 74.34%	28,075 $16,000
Q3 2021 Nov 12, 2021	BUY	$1.21 - $1.8 $14,641 - $21,780	12,100 Added 302.2%	16,104 $27,000
Q2 2021 Aug 06, 2021	SELL	$1.56 - $1.98 $31,356 - $39,798	-20,100 Reduced 83.39%	4,004 $7,000
Q1 2021 May 10, 2021	BUY	$1.36 - $2.49 $32,781 - $60,018	24,104 New	24,104 $41,000
Q4 2020 Feb 10, 2021	SELL	$0.75 - $2.76 $27,753 - $102,131	-37,004 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$0.61 - $1.17 $22,572 - $43,294	37,004 New	37,004 $35,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.